- Congenital dyserythropoietic anemia - type II (CDA-II) with long term follow up and iron overload2004 | First Faculty of Medicine
- Successful treatment of iron overload with phlebotomies in two siblings with congenital dyserythropoietic anemia type II (CDA-II)2006 | First Faculty of Medicine
- Výsledek dlouhodobé léčbya přetížení železem u CDA-II krevními odběry +1Publication without faculty affiliation
- Critical Approaches to Discourse Analysis Across Disciplines 20142015 | Faculty of Arts
- Congenital dyserythropoietic anemia - type II (CDA-II) with long term follow up and iron overload2004 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Successful treatment of iron overload with phlebotomies in two siblings with congenital dyserythropoietic anemia type II (CDA-II) +12006 | Faculty of Medicine in Hradec Králové
- How to make a racial war? : a critical discourse analysis of neo-nazi texts2010 | Publication without faculty affiliation
- Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection2016 | First Faculty of Medicine
- Outcomes of long-term maintenance infliximab therapy in adult patients with moderate to severe Crohn's disease from March 2003 to December 2010: A single centre experience2012 | Faculty of Mathematics and Physics
- Multimedia Education and Consultancy2001 | Faculty of Education
- Kritická analýza diskurzu a vnímání evropských hranic.2017 | Faculty of Arts
- Mediální data a kritická analýza diskurzu2023 | Faculty of Social Sciences
- Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- EASD Postgraduate Course of Clinical Diabetes and its Complications. 7.–29. října 2017, Praha2017 | Second Faculty of Medicine
- Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study2016 | First Faculty of Medicine
- Adalimumab biosimilars in the therapy of Crohn's disease and ulcerative colitis: Prospective multicentric clinical monitoring2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine, Third Faculty of Medicine
- Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration2018 | First Faculty of Medicine
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial2017 | Central Library of Charles University, First Faculty of Medicine
- Certolizumab pegol vs. adalimumab v terapii pacientů s revmatoidní artritidou - studie EXXELERATE2017 | Publication without faculty affiliation
- Permanent remission in rheumatoid arthritis - reality or myth?2019 | First Faculty of Medicine
- Vedolizumab as induction and maintenance therapy for Crohn's disease2013 | First Faculty of Medicine
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naive to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy2017 | First Faculty of Medicine
- Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein2018 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis2022 | First Faculty of Medicine
- Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Steady-stat e gadofosveset-enhanced dar k lumen MR-enterographyPublication without faculty affiliation